![Wayne Marshall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Mark Krembil | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Nizar Mahomed | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Glenys Foster-Roberts | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Brian Levitt | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Canada | 4 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Wayne Marshall
- Réseau Personnel